The objective of this study was to test the hypothesis that COL4A1/A2 is a protective factor in AAA disease combining a novel mouse model of Col4a1/a2 deficiency with proteomic analysis of non-lesioned artery and AAA tissue from human patients. This evidence concerns the gene COL4A1 and triple-A syndrome.